Insider · CIK 0001826322
Peter Virsik
Files at EPIX (ESSA Pharma Inc.). First filing Jan 8, 2024, latest May 6, 2024.
In brief
Peter Virsik files SEC Form 4 as COO at EPIX (ESSA Pharma Inc.). Since Jan 8, 2024, Peter Virsik has reported 0 open-market buys worth $0 and 7 open-market sells worth $798k, the latest filed on May 6, 2024.
A track record needs three past buys with six months of prices behind them; Peter Virsik has 0, so none is measured yet.
The newest scored trade: sold $4,823 of EPIX on May 6, 2024, filed May 6, 2024, scored 0 (weak), under a 10b5-1 plan.
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 0Weak | ESSA Pharma Inc. | $4,823 694 shares | -6% | - | |
| 0Weak | ESSA Pharma Inc. | $5,510 694 shares | -5% | - | |
| 0Weak | ESSA Pharma Inc. | $6,232 694 shares | -5% | - | |
| 26Weak | ESSA Pharma Inc. | $749k 72,782 shares | -85% | - | |
| 0Weak | ESSA Pharma Inc. | $11k 1,194 shares | -9% | - | |
| 0Weak | ESSA Pharma Inc. | $17k 1,718 shares | -11% | - | |
| 0Weak | ESSA Pharma Inc. | $4,271 699 shares | -5% | - |
Planned sales
Form 144 notices this insider filed before selling restricted or control stock, newest first.
| Filed | Company | Shares | Value | Sale date | Past 3 months |
|---|---|---|---|---|---|
| Sep 3, 2024 | EPIX ESSA Pharma Inc. | 4,164 0.01% of outstanding | $23k | Sep 3, 2024 | none |
| Apr 5, 2024 | EPIX ESSA Pharma Inc. | 2,082 0.00% of outstanding | $17k | Apr 5, 2024 | $788k |
| Jan 16, 2024 | EPIX ESSA Pharma Inc. | 75,000 0.36% of outstanding | $746k | Jan 16, 2024 | $4,268 |
| Jan 5, 2024 | EPIX ESSA Pharma Inc. | 2,087 0.01% of outstanding | $13k | Jan 5, 2024 | none |
Transactions
Every row this insider has filed, 15 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| May 6, 2024 | EPIX ESSA Pharma Inc. | SOpen-market sale Common Shares10b5-1 | -694 | $6.95 | $4,823 | 11,246 | May 6, 2024 |
| Apr 5, 2024 | EPIX ESSA Pharma Inc. | SOpen-market sale Common Shares10b5-1 | -694 | $7.94 | $5,510 | 11,940 | Apr 5, 2024 |
| Mar 25, 2024 | EPIX ESSA Pharma Inc. | AGrant or award Optionsderivative | +110,000 | $0.00 | $0 | 110,000 | Mar 28, 2024 |
| Mar 5, 2024 | EPIX ESSA Pharma Inc. | SOpen-market sale Common Shares10b5-1 | -694 | $8.98 | $6,232 | 12,634 | Mar 5, 2024 |
| Feb 6, 2024 | EPIX ESSA Pharma Inc. | MOption exercise Common Shares10b5-1 | +72,782 | $3.23 | $235k | 86,110 | Feb 7, 2024 |
| Feb 6, 2024 | EPIX ESSA Pharma Inc. | SOpen-market sale Common Shares10b5-1 | -72,782 | $10.29 | $749k | 13,328 | Feb 7, 2024 |
| Feb 6, 2024 | EPIX ESSA Pharma Inc. | MOption exercise Optionsderivative10b5-1 | -72,782 | $0.00 | $0 | 895,000 | Feb 7, 2024 |
| Feb 5, 2024 | EPIX ESSA Pharma Inc. | SOpen-market sale Common Shares10b5-1 | -694 | $9.25 | $6,420 | 13,328 | Feb 6, 2024 |
| Feb 5, 2024 | EPIX ESSA Pharma Inc. | MOption exercise Common Shares10b5-1 | +500 | $3.23 | $1,615 | 13,828 | Feb 6, 2024 |
| Feb 5, 2024 | EPIX ESSA Pharma Inc. | SOpen-market sale Common Shares10b5-1 | -500 | $10.04 | $5,020 | 13,328 | Feb 6, 2024 |
| Feb 5, 2024 | EPIX ESSA Pharma Inc. | MOption exercise Optionsderivative10b5-1 | -500 | $0.00 | $0 | 967,782 | Feb 6, 2024 |
| Jan 16, 2024 | EPIX ESSA Pharma Inc. | MOption exercise Common Shares10b5-1 | +1,718 | $3.23 | $5,549 | 15,740 | Jan 17, 2024 |
| Jan 16, 2024 | EPIX ESSA Pharma Inc. | SOpen-market sale Common Shares10b5-1 | -1,718 | $10.01 | $17k | 14,022 | Jan 17, 2024 |
| Jan 16, 2024 | EPIX ESSA Pharma Inc. | MOption exercise Optionsderivative10b5-1 | -1,718 | $0.00 | $0 | 968,282 | Jan 17, 2024 |
| Jan 5, 2024 | EPIX ESSA Pharma Inc. | SOpen-market sale Common Shares10b5-1 | -699 | $6.11 | $4,271 | 14,022 | Jan 8, 2024 |
Questions about Peter Virsik
Answered from the filings on this page, as of the latest one.
Is Peter Virsik buying or selling?
Not in the last 12 months. Peter Virsik's latest open-market trade on SEC Form 4 was sold $4,823 of EPIX on May 6, 2024.
How did Peter Virsik's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Peter Virsik has 0.
Where does Peter Virsik file Form 4?
Peter Virsik has filed Form 4 at EPIX (ESSA Pharma Inc.) as Chief Operating Officer. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.